--- title: "Concession for Printing and Marketing of the British Pharmacopoeia" ocid: "ocds-h6vhtk-0335b1" canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-0335b1" markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-0335b1.md" json_url: "https://d3tenders.com/contract/ocds-h6vhtk-0335b1.json" source: "Find A Tender Service" current_stage: "Tender" buyer: "MHRA" published: "2022-06-22" --- # Concession for Printing and Marketing of the British Pharmacopoeia Buyer: MHRA Current stage: Tender OCID: ocds-h6vhtk-0335b1 [View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-0335b1) [Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-0335b1.json) ## Summary The Medicines and Healthcare Products Regulatory Agency (MHRA) is conducting a tender for the "Concession for Printing and Marketing of the British Pharmacopoeia," which falls under publishing services within the health industry. Located in London, the procurement is currently at the planning stage. Key deadlines include the submission deadline for expressions of interest, which is set for 24 June 2022, and the contract is expected to be awarded in July 2022. This tender will result in a concession contract, whereby the selected organisation will handle the printing, publishing, distribution, marketing, and sale of the British Pharmacopoeia (BP) and British Approved Names (BAN) publications. This contract presents significant opportunities for businesses engaged in publishing, printing, or marketing services, particularly those with experience in public health or regulatory compliance. Companies specialised in digital services, web design, and distribution logistics would also benefit from this tender, as the selected contractor will be responsible for developing and maintaining a dedicated website for the BP. The contract allows for collaborations with other organisations, providing a platform for firms to leverage their expertise in consortium arrangements, which could facilitate growth and innovation in service delivery and product development within the pharmaceutical sector. ## Notice The Medicines and Healthcare products Regulatory Agency (the Agency) is an Executive Agency of the Department of Health. We protect and improve the health of millions of people every day through the effective regulation of medicines and medical devices, underpinned by science and research.The British Pharmacopoeia (BP) is the official collection of standards for UK medicinal products and pharmaceutical substances. It is produced by the British Pharmacopoeia Commission Secretariat of the Medicines and Healthcare Products Regulatory Agency, in accordance with regulation 317(1) of the Human Medicines Regulations 2012, and makes an important contribution to public health by setting publicly available standards for the quality of medicines.The Agency requires the appointment of a Concessionaire to be responsible for the printing, publishing, distribution, marketing and selling of the BP and BAN publications. ### Lot Information Lot 1 The British Pharmacopoeia (BP) is the official collection of standards for UK medicinal products and pharmaceutical substances. It is produced by the British Pharmacopoeia Commission Secretariat of the Medicines and Healthcare Products Regulatory Agency, in accordance with Regulation 317(1) of the Human Medicines Regulations 2012 and makes an important contribution to public health by setting publicly available standards for the quality of medicines. Since 1864, the BP has been providing authoritative standards for medicinal products and pharmaceutical substances and it continues to play an important role in the standard-setting process worldwide. Now used in over 100 countries, the BP remains an essential reference for all individuals and organisations working within pharmaceutical research and development, manufacture and testing around the globe. All monographs and requirements of the European Pharmacopoeia (Ph. Eur.) are also reproduced in the BP. The BP is published annually with three in-year updates, currently in both hardcopy and electronic formats; the latter is available as a download product as well as accessed via a single-user licence or a multi-user license arrangement. In addition, there is the requirement for the publication of the British Approved Names (BAN) which provides the official, non-proprietary, or generic names given to pharmaceutical substances, published annually. The Agency requires the appointment of a concessionaire to be responsible for the printing, publishing, distribution, marketing and selling of the BP and BAN publications. A core part of the requirement is the provision and maintenance of a website, which operates as a portal to access the electronic formats of the BP, as well as acting as a source of added value material and a sales platform for the BP chemical reference standards, orders for which are fulfilled by the Agency. The link to the current website is https://www.pharmacopoeia.com/, and this web address is owned by the Agency. The legacy publication content is available as an XML dataset with a DTD and shall be provided to the service provider. The concessionaire would have responsibility for business development and marketing of the product, with the strategic approval of the Agency, and also shall be expected to invest in the services to deliver continuous improvement and innovation throughout the life of the contract. The concessionaire will also need to carefully manage sales and distribution of BP publications to our global user base which is currently conducted through established reseller networks. The Agency wishes to award one concession contract to one contracting party; collaborations with other organisations to bring together the range of expertise (via sub-contracting/consortium arrangements) would be acceptable, with the concessionaire ensuring effective and seamless delivery. The appointed concessionaire shall retain the revenue from the service/sales as its fees minus the payment of agreed royalty fees to the Agency. The concessionaire shall have exclusivity on the sales of the BP and BAN. Pricing strategies shall be reviewed and agreed by both parties. This contracting approach is the same as the current set-up. We expect to award and agree a contract July 2022 to facilitate sufficient lead time for implementation and the publication of the BP2024 in August 2023. ## Key Details | Field | Value | | --- | --- | | Publication source | Find A Tender Service | | Latest notice | https://www.find-tender.service.gov.uk/Notice/017029-2022 | | Notice type | Tender Notice | | Procurement type | Standard | | Procurement category | Services | | Procurement method | Not Specified | | Procurement method details | Not specified | | Tender suitability | Not specified | | Awardee scale | Not specified | | All stages | Tender | ## Dates | Field | Value | | --- | --- | | Publication date | 22 Jun 2022 | | Submission deadline | 23 May 2022 | | Future notice date | Not specified | | Award date | Not specified | | Contract period | Not specified | | Recurrence | Not specified | ## Values | Field | Value | | --- | --- | | Tender value | Not specified | | Lots value | Not specified | | Awards value | Not specified | | Contracts value | Not specified | ## Status | Field | Value | | --- | --- | | Tender status | Active | | Lots status | Active | | Awards status | Not specified | | Contracts status | Not specified | ## Buyer | Field | Value | | --- | --- | | Main buyer | MHRA | | Locality | LONDON | | Post town | East London | | Postcode | E14 4PU | | Country | England | | ITL 1 | TLI London | | ITL 2 | TLI4 Inner London - East | | ITL 3 | TLI42 Tower Hamlets | | Local authority | Tower Hamlets | | Electoral ward | Canary Wharf | | Westminster constituency | Poplar and Limehouse | | Delivery location | Not specified | ## CPV Codes ### Divisions - 72 - IT services: consulting, software development, Internet and support - 79 - Business services: law, marketing, consulting, recruitment, printing and security ### Codes - 72413000 - World wide web (www) site design services - 79342000 - Marketing services - 79811000 - Digital printing services - 79824000 - Printing and distribution services - 79970000 - Publishing services ## Release History - 22 Jun 2022 at 10:52 - TenderUpdate - Tender Notice - https://www.find-tender.service.gov.uk/Notice/017029-2022 - 13 May 2022 at 15:53 - TenderUpdate - Tender Notice - https://www.find-tender.service.gov.uk/Notice/012546-2022 - 9 May 2022 at 16:02 - Tender - Tender Notice - https://www.find-tender.service.gov.uk/Notice/012052-2022 ## Notice URLs - http://health.atamis.co.uk - https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency - https://www.pharmacopoeia.com/ ## Provenance This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-0335b1. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-0335b1.json.